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ABSTRACT  This  study describes  the  preparation  of a  membrane  subfraction  from  isolated 
nerve  growth  cone  particles  (GCPs) (see Pfenninger,  K.  H.,  L.  Ellis, M.  P.  Johnson,  L.  B. 
Friedman,  and S. Somlo,  1983,  Cell,  35:573-584) and the identification  in this fraction of a 
glycoprotein  expressed  during neurite growth.  While  ~40 major polypeptides are visible  in 
Coomassie  Blue-stained SDS polyacrylamide gels of pelleted (partially disrupted) GCPs, a salt- 
washed membrane fraction prepared from lysed, detergent-permeabilized GCPs contains only 
14% of this protein and has an unusually simple polypeptide pattern of seven  major bands. 
Monoclonal antibodies have been generated to GCP membranes  isolated  from fetal rat brain. 
These antibodies have been screened differentially with synaptosomes  from adult rat brain  in 
order to identify those which recognize antigens expressed selectively during neurite growth. 
One such antibody (termed  5B4) recognizes  a developmentally  regulated membrane  glyco- 
protein that is enriched in GCP membranes  and expressed  in fetal neurons sprouting in vitro. 
The 5B4 antigen in fetal brain  migrates in SDS polyacrylamide gels as a diffuse band of ~185- 
255  kD,  is rich  in sialic  acid, and consists of a small family of isoelectric variants.  Freezing- 
thawing and neuraminidase digestion result in the cleavage of the native antigen into two new 
species  migrating  diffusely  around  200  and  160  kD.  Prolonged  neuraminidase  digestion 
sharpens  these bands at about  180 and  135 kD,  respectively.  In the mature brain,  antibody 
5B4 recognizes a sparse polypeptide migrating at ~140 kD. As shown in the following paper 
(Wallis,  I., L. Ellis, K. Suh, and K. H.  Pfenninger,  1985, J. Cell Biol.,  101:1990-1998), the fetal 
antigen  is specifically associated  with  regions  of neuronal sprouting and, therefore,  can  be 
used as a molecular marker of neurite growth. 
The biochemical analysis of growth cones of sprouting neu- 
rons has been limited by the  inability heretofore to isolate 
these structures in sufficient quantity. A further difficulty is 
the structural complexity of the growth cone: in addition to 
the plasma membrane, it contains several types of organelle 
including endomembrane systems (4,  10, 58, 67). In previous 
publications,  we have described a  subcellular fraction from 
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fetal rat brain highly enriched in particles that (a) have all the 
cytological characteristics of nerve growth cones (40), (b) co- 
purify with nerve growth cones microdissected from cultures 
(40), and (c) contain a complement of phosphoproteins char- 
acteristic of neurons (for review see,  e.g.,  reference 36),  in- 
cluding synapsin I and its kinase (11,  28). 
We describe here the preparation of a membrane subfrac- 
1977 tion (GCM) l of the nerve growth cone particle (GCP). These 
membranes contain a simplified  set of polypeptides and can 
be  prepared  in  sufficient quantity  (100-#g  amounts)  for the 
generation of polyclonal and monoclonal  antibodies (mAb's) 
against their components.  The preparation of such antibodies 
was based on the following rationale.  During embryogenesis, 
the  neuron  undergoes  dramatic  changes in  phenotype  as  it 
differentiates from a  dividing neuroepithelial cell into a  post- 
mitotic,  sprouting  neuron  and,  finally,  into  a  neuron  with 
synaptic  connections  with  the  appropriate  target  cells.  One 
experimental approach to the analysis of growth-specific mol- 
ecules  is  the  immunochemical  comparison  of components 
expressed during specific stages of neuronal development, e.g., 
components  present in GCPs vs. synaptosomes (their mature 
counterpart  from adult brain).  The availability of substantial 
quantities of GCPs and synaptosomes makes it feasible to use 
these  subcellular  fractions  as  antigens  for the generation  of 
mAb's.  One  can  then  select  the  antibodies  that  recognize 
developmentally  regulated  neuronal  antigens  by  screening 
differentially with both fractions. In a  report to be published 
shortly we will describe an antigen expressed in synaptosomes 
but  not in GCPs  (cf.  reference 62).  In the present study, we 
describe a  mAb which recognizes a developmentally regulated 
neuronal antigen of GCP  membranes  that is present only in 
very  small  amounts  in  synaptosome  fractions.  The  antigen 
exhibits  biochemical  properties  consistent  with  those  of  a 
polysialylated membrane  glycoprotein. Preliminary reports of 
these findings have been presented in abstract form (62, 63). 
MATERIALS  AND  METHODS 
Materials 
Ultrapure sucrose was from Schwarz/Mann Div., Cambridge,  MA. N-Tris- 
[hydroxymethyl]methyl-2-aminoethanesulfonic  acid  (TES),  Tris(hydroxy- 
methyl)aminomethane (Tris, as Trizma base), aminopterine, thymidine, soy- 
bean trypsin inhibitor,  DNAase 1, and all protease inhibitors were from Sigma 
Chemical  Co.,  St.  Louis,  MO.  Trypsin was from Worthington Biochemical 
Corp., Freehold,  NJ. Protein standards for SDS PAGE were from Pharmacia 
Fine Chemicals,  Piscataway,  N  J, and Bio-Rad Laboratories,  Richmond, CA. 
Calbiochem-Behring  Co., La Jolla, CA, supplied neuraminidase and hypoxan- 
thine. SDS was from British Drug House (obtained through Gallard-Schlesinger 
Chemical  Mfg. Corp., Carle  Place, NY). Ampholytes were from LKB Instru- 
ments, Inc., Paramus,  NJ. All chemicals for SDS PAGE were electrophoresis 
grade. 4-Chloro-l-naphthol was obtained from Aldrich Chemical Co., Milwau- 
kee,  WI.  All  other chemicals were  reagent  grade.  Nitrocellulose  was  from 
Schleicher & Schuell,  Inc.,  Keene, NH (BA85, 0.45 #m).  Immunochemicals 
were  from  Boehringer  Mannheim  Biochemicals,  Indianapolis,  IN.  Culture 
media were  from Gibco Laboratories,  Grand  Island,  NY,  and  fetal bovine 
serum was from Flow Laboratories,  Inc., McLean, VA. 
Subcellular Fractions and Membrane Preparations 
All membrane fractions  were prepared from adult or developing brains of 
Sprague-Dawley rats. The gestational  age of fetal rats is indicated counting the 
plug date as day 0. 
CRUDE  MEMBRANE  PREPARATIONS:  Crude membrane preparations 
were generated by homogenizing the brains gently (Teflon/glass  homogenizer) 
in ~6 vol of 0.32 M sucrose containing 1 mM MgC6 and  1 mM TES buffer 
(pH 7.3). Homogenates were spun at 1,660 gma for 15 min in a Beckman JA- 
17 rotor, the pellet was discarded, and the supernatant pelleted at 100,000 g,~,~ 
for 60  rain in  a  Beckman  SW55Ti  rotor (Beckman  Instruments, Inc.,  Palo 
t Abbreviations  used in this paper:  BSA-P,  1% bovine serum albu- 
min-phosphate  buffer;  DIA,  dot-immunobinding  assay;  GCMs, 
growth cone particle membranes; GCPs, growth cone particles; IEF, 
isoelectric focusing; mAb's, monoclonal antibodies; N-CAM, neural 
cell adhesion molecule; SS, synaptosome; TBSA, 3% bovine serum 
albumin in 50 mM Tris-HC1, pH 7.3, plus 150 mM NaC1. 
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Alto, CA). The pellets were then resuspended  in the appropriate buffer system 
for dot-immunobinding assay (DIA) or gel electrophoresis as indicated below. 
GROWTH CONE PARTICLES (GCPS);  GCPs were prepared from  17- 
18-d fetal brains according to the two-step procedure described by Pfenninger 
et al. (40). The resulting "A fraction" was diluted three- to fourfold with 0.32 
M sucrose (with  l mM MgClz and l mM TES buffer, pH 7.3) and pelleted at 
39,800 gm~ for 30 min at 4°C. This GCP pellet (Pl) was resuspended  for use 
as described  or processed  further for the generation  of GCP membranes as 
indicated  below.  In many situations  (see text), GCPs and membranes were 
prepared in the presence of the following protease inhibitors: phenylmethylsul- 
fonyl fluoride (1 raM), soybean trypsin inhibitor(type I-S; 100 gg/ml), pepstatin 
A (l gg/ml), and leupeptin (30 #M). 
GCP  MEMBRANES (GCMS):  GCMs were prepared from the "A-fraction" 
pellet as follows (see Fig. 1): GCPs were lysed by resuspending the pellet (PI) 
in 0.5 ml of 6 mM Tris-HCl, pH 8.1, containing 0.5 mM EDTA, adding Tris/ 
EDTA to a volume of 4 ml, and then stirring at 4"C for 45 rain (cf. reference 
9).  The lysed  material  was  loaded  onto a  1.0-ml cushion of 1 M  sucrose 
containing 0.5 mM EDTA and spun at 200,000 g.~ for 60 min at 4"C in a 
SW55Ti rotor (Beckman  L8-55). 
SOLUBLE PROTEINS ($2):  S2 were precipitated  from the lysate by the 
addition of 50% ice-cold trichloroacetic  acid to a final concentration of 8.3% 
and collected by centrifugation  (11,200 g,~ for 20 min at 4°C). The resulting 
pellet was washed three times with ice-cold diethylether to remove the trichlo- 
roacetic  acid  (15)  and  solubilized  in  sample buffer for electrophoresis  (see 
below). 
MEMBRANE  FRACTION;  The crude membrane fraction was collected at 
the Tris/sucrose interface and treated with 5 ml of 0.3 M Na2SO4 plus 20 ug/ 
ml saponin for 30 min at 4°C, with stirring (6). The washed membranes were 
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FIGURE  1  Flow diagram of the preparation of growth cone mem- 
branes. collected by centrifugation at 200,000 g,,~ for 60 min at 4"C. The pellet (P3) 
was washed twice with water, resuspended in 50 #1 of water by homogenization 
in a glass-glass grinder (Bees-Knees; Pierce Chemical Co., Rockford, IL), and 
either prepared immediately for SDS  PAGE by adding an equal volume of 
twice-concentrated sample buffer (31) or stored frozen at -20"C until used. 
Proteins in the final supernatant ($3) were precipitated and collected as above 
for $2.  In some experiments, all solutions contained the protease inhibitors 
mentioned above. 
For  a  series of experiments, GCMs  were  incubated at  37"C  for  various 
periods of time with neuraminidase (from  Vibrio cholerae; O. 125 IU/ml). The 
incubation medium consisted of 0.05 M sodium acetate buffer, pH 5.0, 2 mM 
CaCI2,  and 0.2 mM EDTA, with the protease inhibitors listed above. Approxi- 
mately 100 ug of sample proteins was incubated in a total volume of 200 ul. 
Control membranes were incubated in the same solutions, but without neura- 
minidase. After incubation, membranes were pelleted and then dissolved in 
sample buffer for electrophoresis. 
SVNAPTOSOMES  (SS'S):  SS's (16) were prepared  from adult rat brain 
essentially according to  the  procedure  of  Cohen  et  al.  (9).  Cortices  were 
homogenized in 0.32  M  sucrose containing 1 mM  NaHCO3,  1 mM  MgCI2, 
and 0.5  mM  CaCI2 (solution A), at a  ratio of 10%  wet wt/vol, and filtered 
through a  100-um nylon mesh screen. The  1,400 gay (10 rain, Beckman JA-17 
rotor) supernatant of this filtrate was centrifuged at 13,800 g,v for 10 rain (JA- 
17 rotor). The pellet was homogenized in  1.5 ml of 0.32 M sucrose plus 1 mM 
NaHCO3 (solution B), and layered onto a three-step sucrose density gradient 
(2.6 M:7 ml; 1.2 M: 15 ml; 1.0 M:I 5 ml). This gradient was spun at 131,700 g,v 
using a  vertical rotor (Beckman VTi50) for 40 rain. The band formed at the 
1.0/1.2 M  sucrose interface was collected, diluted in 4 vol of solution A, and 
pelleted for 30 rain at 27,200 g.v. The pelleted SS fraction was resuspended in 
phosphate-buffered saline (PBS), homogenized, and frozen away in aliquots for 
later use. 
Generation of mAb's 
The technique used for the production of mAb's was based on the original 
work of Kohler and Milstein (30), as modified by Sharon et al. (52). BALB/c 
mice were given an initial intraperitoneal (i.p.) injection of pelleted GCPs (400 
#g protein) in PBS,  mixed 1:1 with Freund's complete adjuvant. Over a period 
of  months  mice  were  boosted  with  i.p.  injections  of GCPs  plus  Freund's 
incomplete adjuvant, and then given a  final intravenous (i.v.) injection with 
salt-washed GCMs in PBS. 4 d after the i.v. injection, the spleen was aseptically 
removed from an immunized mouse, and splenocytes were prepared. Spleno- 
cytes were fused with a  k-chain-secreting myeloma cell line (45.6.TG.1.7.5) 
using PEG-1000 (J. T. Baker Chemical Co., Phillipsburg, N J). Cells were fused 
at a  ratio of 10  splenocytes to  1 myeloma and plated overnight in  Iscove's 
medium plus 20% fetal calf serum at 37"C,  in the presence of 4% CO2 in air. 
The following day, the ceils were pelleted through a cushion of 100%  fetal calf 
serum ( 140 g for 10 min) and resuspended in a  1:1 mixture of lscove's medium 
with  20%  fetal  calf serum  and  myeloma-conditioned medium,  plus  HAT 
components (10  -4 M  hypoxanthine, 10  -5 M  aminopterine, and 3.0 ×  10  -5 M 
thymidine). The resuspended cells were plated into 96-well microtiter plates at 
a density of 125,000 cells/well. The cells were maintained at 37°C in air with 
4% CO2 added.  Hybrids were fed on days 5 and  10 after the fusion and then 
switched to  HAT  medium  minus the aminopterin. Wells containing >50% 
confluent hybridoma growth were assayed for antibody production. 
DIFFERENTIAL  SCREENING  OF  HYBRIDOMAS:  Selected wellswere 
screened for the presence of antibodies that would differentially recognize GCPs 
but not synaptosomes in either an enzyme-linked immunosorbent assay (see 
reference 12) or a DIA (see reference 19). Briefly, 1 ul of GCPs or SS's in Tris- 
buffered saline (50 mM Tris-HCl, pH  7.3,  plus 150 mM NaCI) were spotted 
onto a nitrocellulose filter grid at a concentration of I #g protein/#l. Remaining 
reactive areas of the filter were blocked with 3% bovine serum albumin (BSA) 
in Tris-buffered saline (TBSA), and the individual filters were incubated with 
supernatants from selected hybridoma wells diluted two- to fourfold in TBSA. 
After washing with TBSA, the filters were incubated with an immunoaffinity- 
purified goat anti-mouse-IgG conjugated to horseradish peroxidase. Filters were 
again washed with TBSA and reacted with the chromogenic substrate 4-chloro- 
l-naphthol. Supernatants binding to the spotted antigens on the filter develop 
a purplish spot after the substrate incubation. Hybridomas of interest were then 
cloned in semi-solid agarose (52) once or twice, grown in mass culture, and 
then used for the preparation of ascites fluid. Aliquots of the cloned hybrids 
were also frozen away in liquid nitrogen. 
Biochemical Methods 
Protein concentrations were determined according to the method of Brad- 
ford (see reference 3; Bio-Rad reagent), using bovine plasma gamma-globulin 
as standard. Phospholipid phosphorus was determined by a modification of the 
method of Ames and Dubin (1). 
PAGE:  One-dimensional  SDS  PAGE  was  carried  out  according  to 
Laemmli (31, as described in reference 46). All samples were boiled for 3 rain 
in the presence of SDS and beta-mercaptoethanol prior to electrophoresis. Slab 
gels were 140 x  240 x  0.75 ram, with a 20-mm stacking gel of 3% acrylamide. 
They consisted either of a 5-15% linear acrylamide gradient (run for a distance 
of 200 mm in the resolving gel) or of 5% acrylamide (run for a distance of 100 
mm  in  the  resolving gel). Gels were  stained with Coomassie Blue (65)  or 
ammoniacal silver (66). The molecular mass standards were as follows: myosin 
(200 kD), beta-galactosidase (116 kD), phosphorylase b (94 kD), albumin (67 
kD), ovalbumin (43 kD), carbonic anhydrase (30 kD), trypsin inhibitor (20. l 
kD),  and  alpha-lactalbumin (14.4  kD).  Molecular  mass  values  of  blotted 
proteins were determined by extrapolation from the position of blotted protein 
standards; the values indicated are based on separation on 5% acrylamide gels 
and are averages (rounded to the nearest 5  kD) of at least two independent 
determinations. 
Two-dimensional gels with isoelectric focusing (IEF) in the first dimension 
were prepared as described by O'Farrell (37), with the following modifications: 
samples contained about  100 ~tg protein in  60  ul; gels were  130  x  2  ram; 
ampholytes ofpH  5-7 (0.8%), pH 3.5-5 (0.8%), and pH 3.5-10 (0.4%) were 
included in the sample buffer and IEF gels. Second dimension gels were the 
slab gels prepared as described above. 
WESTERN  BLOT  ANALYSIS:  Proteins were transferred electrophoreti- 
cally from SDS PAGE or two-dimensional gels to nitrocellulose paper in an 
electroblot apparatus (E-C Apparatus Corp., St. Petersburg, FL) at 300 mA, for 
l  h  as described by Towbin et al.  (60).  The  resulting blots were processed 
according to the procedure of Hawkes et al. (19). Initially, blots were incubated 
with hybridoma culture supernatant (diluted 1:1  with TBSA.  In later experi- 
ments, different batches of 5B4 ascites fluid, diluted 1:2,000,  were used. mAb's 
bound to the blot were detected with a horseradish peroxidase-conjugated goat 
anti-mouse-lgG (immunoaffinity-purified, light chain- and heavy chain-spe- 
cific). The peroxidase reaction was carried out with 4-chloro-l-naphthol as a 
substrate. Control blots were incubated with either myeloma supernatant or 
with ascites fluid from myeloma-injected mice. 
Morphological Methods 
ELECTRON  MICROSCOPIC  ANALYSIS:  Samples for  electron  micro- 
scopic analysis were prepared as described in a previous paper (40), except that 
high-speed pellets PI and P3 were fixed and embedded in toto in the ultracen- 
trifuge tube. 
CELL  CULTURE  AND  IMMUNOFLUORESCENCE:  Brains from  fetal 
rats at day  18 of gestation were used for the preparation of neural cultures. 
Regions of the cortex were divided into smaller pieces and then incubated in a 
trypsin solution (500 U/ml) at ambient temperature for 8 rain. Soybean trypsin 
inhibitor and DNAase I (4 mg/ml and 0.025 mg/ml, respectively) were added, 
and the dissociated cells were pelleted from solution at -  100 g for 8 min. Cells 
were  resuspended  in  medium  and  plated  into  35-mm  poly-o-lysine-coated 
plastic dishes. The cells were grown in F-12 medium containing 10% fetal calf 
serum, insulin, transferrin, progesterone, putrescine, selenous acid, and estra- 
diol (all from Sigma Chemical Co., St. Louis, MO) at 37°C, with -3% CO2 in 
humidified air (2). Cultures were maintained for 3 d to 1 wk. 
Cultured cells  were fixed by slowly infusing, directly  into the culture medium, 
a 2% solution of paraformaldehyde in phosphate buffer (0.1  M, pH 7.3). After 
infusion, l0 drops of fixative were added to the plates. After 5 min the cultures 
were drained and fresh 2% paraformaldehyde-phosphate buffer was added with 
a pipette. After 15 min in the fresh fixative, the cultures were carefully washed 
with phosphate buffer. They were then incubated in 1% BSA-phosphate buffer 
(BSA-P)  to  block  any  residual  aldehyde groups;  some  cultures  were  also 
permeabilized by incubating in BSA-P containing 0.02% saponin. Antibodies 
used for incubation were all diluted in BSA-P (all incubation media and washes 
of the permeabilized cultures contained 0.02%  saponin in BSA-P).  Primary 
antibody incubation was with 5114 ascites fluid diluted 500- to  1,000-fold or, 
as a control, with myeloma ascites fluid diluted to the same extent. Incubation 
was for 2 h  at room temperature. Cultures were then washed six times for 5 
rain each time followed by the addition of the secondary antibody. An immu- 
noaffinity-purified goat anti-mouse-lgG conjugated to fluorescein isothiocyan- 
ate, diluted 40-fold, was used as the secondary antibody.  Incubation was as 
above. After 2 h, the cultures were washed six times for 5 min each time and 
partially drained. The sides of the 35-ram dishes were then broken off.  Two 
drops of 50% glycerol in phosphate buffer were placed on the cultures, followed 
by a round coverslip which was sealed in place with nail polish. The cultures 
were observed using a Leitz Ortholux microscope equipped with epifluorescence 
optics. 
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Preparation of GCMs 
GCPs  consist  of  sheared-off,  membrane-bound  cellular 
fragments  that  have  the  ultrastructural  features  of  nerve 
growth  cones  (cf.  Fig.  2):  they  contain  an  abundance  of 
micro  filaments, large dense-core vesicles,  large clear vesicles, 
elongated agranular reticulum and occasional mitochondria, 
but no ribosomes (40).  If GCPs are separated from soluble 
proteins of the "A-fraction" by chromatography on a column 
of controlled pore glass (40),  they are ultrastructurally intact 
and exclude both the extracellular tracer [3H]inulin  (Clark, 
R., and K. H. Pfenninger, unpublished observations) and 3'- 
32P-ATP  (Hyman, C.,  and  K.  H.  Pfenninger,  unpublished 
observations). More efficient for the large-scale preparation 
of GCPs and for the isolation of membranes from them is a 
second strategy (Fig.  1). The A-fraction is diluted with 0.32 
M  sucrose  and  pelleted  (Pl).  As  illustrated  in  Fig.  3,  P1 
contains  the  GCPs,  but  many of them  have  been  broken 
during pelleting (cf. Fig.  1 in ref.  40).  The A-fraction repre- 
sents ~5% of homogenate protein (5.4 _+ 0.8%; mean _+ SEM, 
n =  13; see ref. 40).  However, P1  contains only ~8% (8.2  _+ 
2.3%; mean _+ SEM, n =  6) of the protein of tbe A-fraction, 
or -0.4% of homogenate protein. 
In  initial  experiments,  P1  was  treated  with  a  hypotonic 
buffer at basic pH (6 mM Tris-HC1,  pH 8.1),  rapidly frozen 
in liquid nitrogen, and then thawed to assist in the lysis of the 
GCPs. Finally, the membranes were collected as a high-speed 
pellet (200,000  gmax for 60  min).  However, the  membranes 
collected in  this  manner are  frequently  resealed and  often 
have electron-dense fibrillar material attached to them (data 
not shown). Furthermore, aggregates of electron-dense mate- 
rial and organelles, such as mitochondria, contaminate this 
membrane  preparation.  Therefore,  the  protocol  has  been 
modified as follows (cf. Fig. 1): P 1 is resuspended in hypotonic 
Tris-HCl as before, but with 0.5  mM EDTA added to assist 
with lysis of the particles; furthermore, the crude membrane 
fraction is spun onto a  1.0-M sucrose cushion. While heavier 
elements, such as mitochondria and lysosomes, are pelleted 
(P2),  the lighter membrane sacs band at the  1.0-M  sucrose 
interface. The crude membranes are then washed in a solution 
of high  ionic  strength  (0.3  M  Na2SO4) containing  a  low 
concentration of the non-ionic detergent saponin (20 vg/ml) 
to permeabilize any resealed membrane vesicles. The washed 
membranes are collected as a high speed pellet (P3).  Electron 
microscopic analysis  of P3  reveals a  highly  homogeneous 
membrane preparation (Fig. 4). At higher magnification (Fig. 
5),  the  bilayer of the  membranes is  seen  to  be intact,  the 
membrane surfaces are essentially free of adsorbed electron- 
dense  protein,  and  the  pellet  is  devoid  of any identifiable 
organelles or amorphous debris. The protein yield of  the GCM 
preparation, P3, is  13.7 +  1.1% (mean _  SEM, n =  7) with 
respect to  P1.  The removal of >85%  of the protein of the 
already disrupted  GCPs  (i.e.,  P1)  during  this  procedure  is 
accompanied by an increase in the ratio of phospholipid to 
protein (based on phospholipid phosphorus) in the final GCM 
pellet  (P3).  The  protein-to-phospholipid  ratio  is  decreased 
from -3.5 in P1  to -0.95 in P3 (average of two determina- 
tions; data not shown). 
Polypeptides of the GCP and GCMs 
The  polypeptide pattern  of pelleted  OCPs  (P1)  on  one- 
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dimensional SDS polyacrylamide gels is comprised of 40 or 
70 bands when stained with Coomassie Blue or silver, respec- 
tively (Fig. 6, GCP). Upon hypotonic lysis of the particles at 
basic pH, the majority of the bands visible in the GCP lane 
are also present in the lysate ($2) (LYS in Fig. 6), including 
prominent bands of 52 and 42 kD. Under one-dimensional 
gel electrophoresis, tubulin purified from adult rat brain (cf. 
ref. 55) forms a single,  broad band (the a  and fl subunits are 
not well resolved) that co-electrophoreses with the major GCP 
and lysate band visible at 52 kD. Furthermore, actin (prepared 
as actomyosin from mouse  heart;  see  reference  17)  co-mi- 
grates with the 42-kD major band (data not shown). 
In contrast to the GCP lysate, the washed GCMs (Fig.  6, 
GCM) contain a simple polypeptide pattern, with major bands 
of 52, 46, and 42 kD, and doublets at 38 and 34 kD. Certain 
of  these major bands (38 and 34 kD) are substantially enriched 
compared to the GCP pattern and are represented minimally, 
if at all, in the lysate. A similar pattern of GCM polypeptides 
is observed when gels are stained with silver (Fig. 6). 
Selection of Monoclonal Antibodies and 
Subcellular Localization of the 5B4 Antigen 
The fusion of myeloma cells with splenocytes from GCP/ 
GCM-immunized mice resulted in ~200 hybridomas. Each 
hybridoma supernatant was screened differentially by an en- 
zyme-linked immunosorbent assay of GCP vs.  SS  protein. 
This technique identified a  total of ~50 hybridomas whose 
antibodies recognized either GCPs or synaptosomes or both. 
A family of such hybridomas, six subelones of 5B4, secreted 
an mAb which reacted with the GCPs but not the SS's.  The 
result of one of these initial screening tests is shown in Fig. 7. 
Even using a 10-fold amount of protein (5 tzg) for SS vs. GCP 
and 5B4 ascites fluid, we failed to detect antibody binding to 
SS.  Subclone  5B44,  forthwith  called  5B4,  was  selected  for 
further analysis. This mAb is of the type IgGl as determined 
by double-diffusion tests with  antisera to specific IgG sub- 
classes  of the mouse, mAb 5B4 was tested on immunoblots 
of GCP polypeptides separated by SDS PAGE (on either 5- 
15% gradient or 5%  acrylamide gels).  5B4  stains a  unique 
band that  is  considerably larger than  the  200-kD standard 
(not shown),  but not visible after Coomassie Blue or silver 
staining of companion gels. 
Two approaches were used to study whether the 5B4 anti- 
gen  is  present  in  GCMs  and  nerve  growth  cones.  These 
consisted (a) of assaying for the enrichment of  the 5B4 antigen 
in the GCP and GCM fractions from fetal brain and (b) of 
studying by immunofluorescence its distribution  in  central 
nervous system neurons sprouting in vitro. The distribution 
of the 5B4 antigen in vivo is described in the following paper 
(64).  For the biochemical analysis, we loaded on SDS poly- 
acrylamide gels  (5%  acrylamide) equal amounts of protein 
from each of the various fractionation steps used to prepare 
GCMs (cf. Fig.  1), prepared immunoblots, and stained them 
with mAb 5B4. The results of this study are shown in Fig. 8. 
Homogenate (H), low-speed supernatant and pellet (LSS and 
LSP, respectively) exhibit quite low levels of immunoreactiv- 
ity, in the form of a broad, sometimes heterogeneous band of 
-185-255 kD (cf. Figs.  l0 and  13). The particulate subfrac- 
tions of the LSS (GCPs, B, and C; see reference 40) contain 
considerably more antigen.  A  dramatic  further increase  in 
antigen content is found in GCM. It is important to note that 
these membranes were washed at a  high salt concentration FIGURES 2-5  (Figs. 2 and 3) Electron micrographs of GCPs fixed in suspension (Fig. 2) or after pelleting (Fig. 3).  Note that many 
of the GCPs in  Fig. 3 are broken and/or lysed whereas those fixed in suspension are intact. (Figs. 4 and 5) Electron micrographs 
of salt-washed membrane pellet (P3).  Note that the field is homogenous (Fig. 4) and consists entirely of membranes. At higher 
magnification (Fig. 5), the membrane bilayers can be seen to be intact and essentially free from contamination. Bars,  1 ~m. 
prior to electrophoresis in order to minimize the amount of 
adsorbed non-membrane proteins. In the GCM preparation, 
we often find broadening of the stained band and, sometimes, 
an additional weak band of considerably smaller molecular 
weight (see below). Omission of protease inhibitors during the 
fractionation  procedure  and  repeated  freeze-thaw steps in- 
ELLIS ET AL.  Neurite Growth  associated Glycoprotein  1981 FIGURE  6  Analysis  of  polypeptides at  different  stages of  GCM 
preparation. Gels are 5-15% polyacrylamide  gradients, stained with 
Coomassie Blue  (lanes  1-3;  CB) or silver (lanes 4  and  5; Ag).  All 
lanes are from a single gel. They show: GCP, pelleted GCPs (P1); 
LYS, lysate ($2); GCM', GCP membrane pellet (P3). The position of 
molecular mass standards  for the Coomassie Blue-stained gels is 
shown on  the  left; for the silver-stained gel,  the positions of the 
same standards (from 14 to 94  kD) are indicated by the marks on 
the  right.  Apparent  molecular  masses calculated  for  the  major 
polypeptide bands of the GCM are also indicated (x 103). A staining 
artifact in the silver-stained gels is indicated by the single  arrow- 
head, and the dye front by double arrowheads. 
FIGURE  7  DIA  with  mAb 
5B4,  comparing  synapto- 
somes (SS) and GCPs. Note 
selective  staining  of  GCP 
material. 
crease the appearance of the lower molecular weight species 
stained in immunoblots. 
The distribution  of the  5B4  antigen in  the intact  neuron 
was  studied  by  indirect  immunofluorescence,  using  disso- 
ciated  cells  from  fetal  cerebral  cortex  grown  in  culture  for 
several days.  In pilot experiments, the antigen was found to 
be  highly  sensitive  to glutaraldehyde  but  not denatured by 
paraformaldehyde. The patterns of immunolabeling of para- 
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FIGURE  8  Immunoblot to show enrichment of the 5B4 antigen in 
GCPs and GCP membranes (GCM). Equal amounts of protein (100 
pg) were loaded in  each  lane and electrophoresed on  5% acryl- 
amide gels before being blotted and immunostained. The designa- 
tion of the fractions is as in  Pfenninger  et al. (40): H,  homogenate 
of F17 fetal brain; LSS, low-speed supernatant (parent fraction of 
GCP, B,  C);  LSP, low-speed pellet; B,  C,  heavy,  heterogeneous 
subfractions  of  LSS  (0.78:1.0  M  sucrose  and  1.0:2.6  M  sucrose, 
respectively), known to contain neurite shafts and GCP fragments; 
GCM, prepared from GCPs as described. The top of this gel (not 
visible) would be just above the lettering. Dots on the right indicate 
position of molecular mass markers: 200,  116, 94, and 67 kD. Note 
the enrichment of the 5B4 antigen in GCM. As described further 
below, extensive processing of the material (as for GCMs) leads to 
broadening of the reactive band. In the heavily overloaded GCM 
lane, a trace of a small degradation product is seen at ~90 kD. 
formaldehyde-fixed  neurons,  intact  or  permeabilized  with 
saponin, are shown in Fig. 9. No fluorescence can be observed 
in controls with myeloma-conditioned medium (in the pres- 
ence  or absence  of saponin)  or in  labeling  experiments  in 
which the cells were not permeabilized with saponin.  How- 
ever,  specific  fluorescence  is  seen  if labeling  with  the  5B4 
antibody  is  performed  in  the  presence  of a  permeabilizing 
agent. As will be reported in the following paper in detail (64), 
only neurons are stained  in  these  cultures.  Their perikarya 
are  outlined  by  fluorescence along  the  plasma  membrane. 
Neurite shafts are also fluorescent. The brightest fluorescence 
is often seen at the nerve growth cone, especially in its basal 
region. 
Biochemical Characterization of the  5B4 Antigen 
The appearance of the 5B4  antigen on immunoblots as a 
broad  smear suggests that  it  may be  microheterogenous in 
form, possibly due to differences in glycosylation. To inves- 
tigate the possible  involvement of sialic  acid  residues,  salt- 
washed  GCP  membranes were  subjected  to  neuraminidase 
digestion prior to electrophoresis and immunoblotting. First 
we examined the commercially obtained neuraminidase for FIGURE  9  Indirect  immunofluorescence 
with mAb 5B4 of dissociated neurons grown 
in  vitro. (Left) Staining  with control ascites 
fluid  (CM),  after  cell  permeabilization (+ 
saponin).  (Center) 5B4 staining  of permea- 
bilized neuron. (Right) 5B4 staining without 
permeabilization (-  saponin).  Demonstra- 
tion of the 5B4 antigen necessitates  mem- 
brane permeabilization.  Note, in the center, 
ring-like fluorescence around  the  perikar- 
yon, the fluorescent outline of growth cone 
lamellopodia and  neurite  shaft,  and  the 
bright  fluorescence  at  the  base  of  the 
growth cone. Non-neuronal cells present in 
this culture are not stained. 
protease activity using the  azo-aibumin assay (7,  59).  Even 
after  16  h  of incubation  at  37"C,  proteolysis could  not  be 
detected in this neuraminidase preparation (data not shown). 
Neuraminidase  digestion  was  carried  out  usually  on  salt- 
washed GCP membranes, freshly prepared and incubated in 
the presence of a cocktail of protease inhibitors (see Materials 
and Methods).  Such membranes, if electrophoresed without 
prior freezing and thawing, generate the single,  diffuse band 
between  185 and 255 kD described earlier and shown in Fig. 
10  (left panel).  Incubation of these GCMs for up to  8 h  at 
37°C in the absence of neuraminidase does not lead to major 
changes in the immunoblot pattern. By  16 h  of incubation, 
the intensity of the stained band is somewhat decreased and 
a second, faint band appears near  160-kD (data not shown). 
In contrast, incubation with neuraminidase for as little as 1/2 
h leads to the appearance of two stained bands of significantly 
greater electrophoretic mobility. Both of these bands are still 
diffuse  but,  with  increasing  neuraminidase  digestion,  they 
become gradually  sharpened  at  ~135  and  185  kD,  respec- 
tively. Note that we observe the highest staining intensity in 
the  samples digested  for  16  h,  indicating  that  the  material 
diffusely distributed over a broad molecular weight range in 
controls has become concentrated to form the sharper bands, 
and  that  most of the  antigenic  material  has been  retained 
during the  incubation  period.  The  smaller,  neuraminidase- 
induced band appears to be similar in size to the 5B4 antigen 
of the mature brain (see below). However, co-electrophoresis 
of the two samples has consistently indicated that the neura- 
minidase-treated fetal antigen migrates slightly faster on 5% 
or 5-15% acrylamide gels (cf. Fig.  11D). 
The appearance of two bands after neuraminidase  treat- 
ment  and  the  diffuse  nature  of the  antigen  in  control gels 
raise the question of whether two or more protein species are 
recognized by the  5B4  antibody. This question  was investi- 
gated using two-dimensional gel electrophoresis. Because of 
the apparent lability of the fetal 5B4 antigen, we used crude 
GCP membranes (high  speed pellet from lysed GCPs,  pre- 
pared in the presence of protease inhibitors) in order to avoid 
its alteration  by elaborate processing. The  freshly prepared 
membranes were immediately solubilized and their proteins 
separated by IEF in the first dimension and  SDS PAGE in 
the second dimension. The immunoblot of such a gel is shown 
in Fig.  11A and reveals a series of vertical streaks indicating 
the  presence of differently charged species of heterogenous 
molecular weight.The pI's range from ~5.1  to ~5.3, and the 
molecular mass varies from -185 to ~255 kD. Next, GCMs 
were prepared in  the  presence of protease inhibitors,  incu- 
bated for  16  h  in  the  absence of neuraminidase  (but  with 
protease inhibitors  present), and  again  analyzed by two-di- 
mensional  gel  electrophoresis  and  immunoblotting  (Fig. 
11 B).  Again, a  series of vertical streaks is evident, but their 
pI's range  from ~4.7  to  ~4.9,  and  their  molecular masses 
from ~ 150 to -210 kD. Neuraminidase treatment drastically 
changes the appearance of the GCM antigen in two-dimen- 
sional gels (Fig.  11 C). The family of vertical steaks observed 
in  the  controls just  described  has  been  shifted  to  a  more 
ELLIS  ET  AL.  Neurite Growth-associated  Glycoprotein  1983 FIGURE  10  The effect of neuraminidase treatment on the fetal 5B4 antigen, in the presence of protease inhibitors. GCM were 
prepared in  the  presence of the  inhibitors, and  the  incubated samples  (equal  aliquots of  100  ug  membrane protein) were 
immediately processed  for electrophoresis and immunoblotting. The marker dots indicate 250,  185, and  140 kD. Unincubated 
and control-incubated GCMs  show a single  but diffuse band between 185 and 255  kD.  By 8 and 16 h (not shown) of control- 
incubation, there is slight fading of the original band, with appearance of diffuse 5B4-reactive material between 140 and 185 kD. 
However, neuraminidase treatment for as little as one half an hour cleaves the native fetal antigen into two diffuse bands with 
relatively sharp lower margins at 135 and 185 kD, respectively. Extended neuraminidase digestion slowly sharpens these bands, 
without apparent loss of antigenicity. 
alkaline pI and condensed to form two series of horizontally 
arranged  spots  (at  135  and  185  kD).  In  each  series,  the 
mobility  in  SDS  PAGE  is  more  or  less  constant  for  the 
majority of protein, but there are four recognizable isoelectric 
variants for the  135-kD group and three such variants for the 
185-kD group. Interestingly, the pI's for the three most acidic 
species in each group seem to be identical (from ~5.1 to 5.2). 
However, the  135-kD group exhibits a  further, slightly more 
basic variant. 
Developmental Regulation of the 5B4 Antigen 
To assess the expression of the 5B4 antigen in brain devel- 
opment,  we first  used a  DIA of crude  membrane  prepared 
from  whole  rat  brains  at  successive  stages  of development. 
Increasing amounts of protein  (12.5  to  1,000 ng) from fetal 
brains at days  13,  16,  19, and 22 of gestation (Fig.  12, F13- 
22) as well as from adult brain (,4) were spotted onto nitro- 
cellulose and then  reacted as described.  The 5B4 antigen  is 
first weakly detectable  on  membranes  prepared  from brain 
on fetal day 13 (F13) and increases steadily towards the time 
of birth (F22). As illustrated  in Fig.  12, the 5B4 antigen can 
be detected with this method in as little as 25 ng membrane 
protein  prepared from  19- or 22-d fetal brains.  Membranes 
prepared  from  adult  rat  brain  exhibit  very  low  levels  of 
immunoreactivity  with  the  5B4  antibody.  Controls carried 
out in parallel,  using myeloma-conditioned medium, do not 
exhibit any nonspecific binding. 
To study whether  mAb 5B4 recognizes the  same antigen 
during brain development, immunoblots were prepared from 
5%  SDS  polyacrylamide gels  of crude  membranes  isolated 
from  developing rat  brain.  Such  a  developmental  series  is 
shown in Fig.  13.  Immunoreactivity in the range of ~ 185- 
255 kD becomes detectable with this method near day 16 of 
gestation. An increase in 5B4 staining is observed at day  19 
of gestation,  and the antigen persists at least until  postnatal 
day 13 (PI3), albeit in diminished quantity. However, at this 
stage of development a second antigen of ~ 140 kD is clearly 
detectable and remains visible in the mature brain (adult, A). 
In heavily overloaded immunoblots of membranes from ma- 
ture brain (->400 ug protein/lane),  one can see a faint second 
band of ~ 185 kD. As already mentioned, the 140-kD antigen 
from  mature  brain  migrates  slightly  but  significantly  more 
slowly in SDS PAGE than the smaller antigen in neuramini- 
dase-treated GCP membranes.  In two-dimensional gels (IEF 
in the first dimension), the mature 5B4 antigen appears as a 
1984  THE  JOURNAL OF  CELL BIOLOGY - VOLUMI"  ]0], ]985 FIGURE  "11  Two-dimensional gel electrophoresis of the 5B4 antigen as localized by immunoblotting. (A) Crude GCP membranes 
(see text); (B) GCM, once frozen and thawed and control-incubated for 16 h; (C) GCM as in B, but incubated with neuraminidase 
for 16 h; (D) crude adult membranes. The two spots on the right margin in D are from a neuraminidase-treated  sample (as in C), 
run only in the second dimension; the arrowhead points at the mature antigen. Note the distinctive vertical streaks indicating 
isoelectric variants  in A-C, the shift in pl to the right during "spontaneous" breakdown (compare A and B) and to the left during 
neuraminidase digestion (compare B and C). Also note that the mature antigen migrates with a slightly larger apparent molecular 
mass than the smaller product of neuraminidase digestion. The dots on the right margin indicate approximate molecular masses: 
250,  185, and 135 kD. 
horizontal band between pI 4.8 and 5.0 (cf. Fig. 11 D). Discrete 
isoelectric variants have not been resolved. 
DISCUSSION 
At present, our knowledge of the biochemical composition of 
the nerve growth cone is very limited. The majority of infor- 
mation available is derived from labeling studies on sprouting 
neurons or neuroblastoma cells grown in vitro.  Cytoskeletal 
proteins such as tubulin  (33,  34,  53),  actin (32-34),  myosin 
(32), neurofilament subunits (53,  54), clathrin (24),  and tim- 
brin (53) have been identified by immunofluorescence. Mi- 
crotubules,  some neurofilaments, and an abundance of mi- 
cro  filaments are evident in electron micrographs (e.g.,  refer- 
ences  22,  23,  54).  Furthermore,  a  few membrane proteins 
have been localized on growth cones: Na  ÷, K÷-ATPase (51), 
the  neural  cell adhesion  molecule, designated  N-CAM  (8), 
and  the  receptor  for  nerve  growth  factor  (5,  29,  48).  In 
addition,  lectin  receptors have been mapped in  the growth 
cone  region  (42,  43,  45).  Yet,  none  of these  components 
appear to be unique to the nerve growth cone, so that bio- 
chemical markers specific for it are not known at the present. 
The availability of milligram quantities of native nerve growth 
cone fragments, however, now renders the biochemical anal- 
ysis  and  the  search  for growth  cone-  or  sprouting-specific 
markers possible. 
The GCM Fraction 
The protocol for GCM preparation includes a step for the 
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somes, and a step for the release of adsorbed proteins (wash 
at high ionic strength in the presence of non-ionic detergent). 
As determined in a previous paper (40) by stereologic analysis, 
80% of the membranes of the GCP fraction consist either of 
plasma membrane or of large clear vesicles. After removal of 
mitochondria (5%) and lysosomal elements (2%), the remain- 
ing membranes (endomembranes exclusive of large clear ves- 
icles) represent ~13%  of GCP membrane. It has been sug- 
FIGURE  12  DIA  to determine 5B4  binding to crude  membranes 
isolated from developing forebrain. Brains were from rat fetus at 13 
to  22  days  of gestation (F13-F22)  and  from an  adult (A) animal. 
Different  concentrations of  membrane protein  were spotted for 
each stage (12.5-1,000 ng/~l).  Binding was carried out with hybri- 
doma supernatant, diluted  1:4, and controls involved the  use of 
myeloma supernatant. For further description, see text. 
gested that the large clear vesicles are the growth cone plas- 
malemma's precursor (38,  39, 41, 42,  44; however, see also 
references 18 and 47, which argue that the vesicles  may be 
fixation artifacts).  Therefore, the GCM preparation, predom- 
inantly composed of plasmalemma and large clear vesicles, 
may in fact represent a closer view of growth cone plasma- 
lemma than would be expected a priori. 
The protein composition of  the intact GCP, when analyzed 
by  SDS  PAGE,  is  complex.  However,  most  of the  GCP 
polypeptides can be released by hypotonic lysis and, therefore, 
are soluble or cytoskeletal components. Thus, the preparation 
of GCMs is accompanied by a marked reduction in protein 
content (14% of P1) and a relative increase in phospholipid 
phosphorus. The protein-to-phospholipid ratio for the washed 
GCMs is -  1.0. This value is probably an overestimate consid- 
ering the presence of actin and tubulin residues in the fraction 
(see  below).  A  relatively low  protein  content  of GCMs  is 
consistent with the results of freeze-fracture studies of nerve 
growth cones in vivo and in vitro, which have demonstrated 
a  low density of intramembrane particles in  both plasma- 
lemma and large clear vesicles (39, 57). 
A particularly striking feature of the GCM preparation is 
the simple pattern of seven major Coomassie Blue-stained 
polypeptides. The identity of most of these major bands is 
not known at present. However, two major polypeptides of 
the GCM, p52 and p42 (which are also major components of 
the intact GCP, the lysate, and the homogenate of fetal brain), 
co-migrate with tubulin and actin, respectively. A more de- 
tailed analysis of the major GCM polypeptides will be pre- 
sented separately (Simkowitz, P., L. Ellis, and K. H. Pfennin- 
ger, manuscript in preparation; see also reference 56). 
Specificity of mAb 5B4 
The generation of mAb's to GCPs and GCMs has led to 
the identification of a large glycoprotein. Based on its relative 
FIGURE 13  Immunoblot of crude membranes prepared from developing rat brain (except for Fll, which contains membranes 
from whole 1  t -d-gestation embryos). Equal amounts of membrane protein (100 ~zg)  were loaded in each lane of two 5% acrylamide 
gels, electrophoresed, blotted, and then reacted with the 5B4 antibody. Because two gels had  to be run and blotted for this 
series, the F19 material {from fetal brains at day 19 of gestation) is shown twice. A, adult forebrain material; P8-P40,  material from 
forebrain of the respective postnatal ages (in days). The markers  on the right side indicate 250  and  140 kD,  respectively. For 
further description, see text. 
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antigen is enriched in, but not unique to, GCMs. However, 
based on Coomassie Blue and silver staining, the antigen is a 
minor GCM component. As determined by our DIA using 
up to  1 ug protein,  mAb  5B4  does not bind at detectable 
levels to crude membranes prepared from rat liver, kidney, or 
muscle  (data  not  shown).  Immunofluorescence studies  on 
cultures of cells dissociated from fetal brain and  on frozen 
sections  of rat  brain  at  various  developmental  stages  (cf. 
following paper [64]) indicate that 5B4 staining is confined to 
neurons.  However, relatively small amounts of antigen (its 
mature form, see below) have been detected in cell lines with 
immunochemical but not with immunofluorescence methods 
(Rosenberg, J., L. Ellis, and C. Kaylar, unpublished observa- 
tions). 
The expression of central nervous system components bind- 
ing mAb 5B4 is developmentally regulated. In the forebrain, 
antigenicity peaks just prior to, and right after birth, when 
axonal growth is extensive and many synapses have yet to be 
formed.  This  applies  specifically to  the  large,  185-255kD 
antigen,  which  is present in  the developing brain  in  much 
greater amounts (on a protein basis) than the cross-reacting, 
140-kD antigen in the mature brain. The large, fetal antigen 
is the molecule enriched in GCMs but essentially absent from 
synaptosomes. Yet, this antigen is not restricted to the growth 
cone because immunofluorescence analysis of isolated grow- 
ing neurons reveals antigenic sites on perikarya and neurites 
as well. Nevertheless, the data presented here and the immu- 
nofluorescence studies described in the following paper (64) 
demonstrate  that  the  large  5B4  antigen  is  associated  with 
neurite formation and, therefore, can be used as a marker for 
this stage of neuronal differentiation. 
It is important to note that the definition of the specificity 
of the large 5B4 antigen is not dependent on the identity or 
the  purity  of our GCP fraction but  rests on  the  results of 
immunochemical assays involving total membranes from de- 
veloping brain and on data obtained by immunofluorescence. 
Therefore, the enrichment of the large 5B4  antigen in GCP 
membranes supports our contention that GCPs are derived 
from growing neurons. 
The Molecular Nature of the 5B4 Antigen 
FETAL  ANTIGEN,  The appearance of this antigen as a 
broad, diffuse band on immunoblots suggests that it is com- 
posed either of a  family of polypeptides that share the  5B4 
epitope  and/or  carries  a  large,  heterogenous  carbohydrate 
portion. The enrichment of the antigen in GCMs washed in 
the  presence of high  ionic  strength--and  its  absence  from 
soluble  fractions--strongly suggests  that it is a  membrane- 
associated molecule, most likely an integral membrane gly- 
coprotein. This interpretation is supported by immunofluo- 
rescence data, i.e.,  ring-like fluorescence around the perikar- 
yon and outline of growth cone filopodia, as well as by the 
results of neuraminidase digestion. Treatment with this en- 
zyme leads to a shift in electrophoretic mobility (sharpening 
of the bands) as well as pI of the antigen, suggesting that the 
antigen is extensively sialylated. The long period of incubation 
required for complete digestion of the 5B4 antigen has also 
been observed by other investigators, for fetal brain antigens 
containing a-2,8-polysialic acid (see below). 
Even in the presence of protease inhibitors, neuraminidase 
induces the appearance of two sets of isoelectric variants of 
significantly different molecular weight.  This observation sug- 
gests that the fetal 5B4 antigen consists of two different, but 
co-migrating glycoproteins, and/or that neuraminidase treat- 
ment of the 5B4  antigen makes a  cleavage site available to 
either an endogenous protease (resistant to the inhibitors used 
in our experiments) or to an (endo)glycosidase (cf.  ref. 20). 
Such a cleavage site would be present and/or become acces- 
sible in only a part of the antigen population, shifting it to a 
considerably lower molecular weight.  It is of interest to note 
that the neuraminidase-digested 5B4  antigen  has three  iso- 
electric variants of 185 kD that seem to have the same pI's as 
three of the four 135-kD variants. 
The neuraminidase digestion experiment also shows that 
antibody binding is resistant to desialylation. This observation 
is consistent with  the  finding that the  labeling of the  5B4 
epitope requires permeabilization of intact cells. This suggests 
that the 5B4 epitope is on an intracellular, subplasmalemmal 
portion  of the  antigen,  whereas the  oligosaccharide chains 
containing sialic  acid are almost certainly located at the cell 
surface (Pfenninger, K. H., and E. Abreu, unpublished obser- 
vations). We conclude, therefore, that the 5B4 antigen consists 
of a heterogenous family of polysialylated, integral membrane 
glycoproteins. 
MATURE ANTIGEN:  mAb 5B4 recognizes in membranes 
from the mature brain a  protein that is only slightly  larger 
(140  kD) and  more acidic than the smaller product of the 
neuraminidase-treated  fetal  antigen.  However,  the  mature 
antigen  is  much  sparser (on  a  protein  basis) than  its  fetal 
counterpart  and  is  virtually absent  from the  synaptosome 
fraction (detectable in blots only when >400 t~g SS protein 
are  used).  Its biochemical  relationship  to the  fetal antigen 
remains to be investigated. 
COMPARISON  WITH  OTHER  NEURAL  ANTIGENS: 
Fetal brain has recently been shown to contain a novel class 
of a-2,8-polysialosyl glycoproteins (13,  14,  35,  61).  Some of 
the  properties characteristic  of these  molecules  have  been 
observed in a  number of closely related or identical, devel- 
opmentally regulated neuronal antigens. These include: chick 
N-CAM (21, 49), rat and mouse N-CAM (8), rat D2 (25-27), 
and mouse BSP-2 (14,  20,  50). The 5B4 antigen shares with 
these glycoproteins the following properties: all are develop- 
mentally regulated neuronal membrane glycoproteins of large 
molecular  weight,  and  in  the  case  of N-CAM/D2/BSP-2, 
neuraminidase  treatment  causes  a  shift  in  electrophoretic 
mobility, approximately to the size of an immunochemically 
similar antigen of the mature brain. BSP-2 has been demon- 
strated  to  contain  c~-2,8-polysialic  acid  (14),  and  the  5B4 
antigen has also been shown to contain such oligosaccharide 
chains (Rosenberg, J.,  L.  Ellis,  F.  A.  Troy, and C.  Kaylar, 
manuscript submitted for publication).  However, there  are 
significant differences in the number and apparent size (a) of 
the neuraminidase cleavage products and (b)  of the mature 
cross-reacting antigens. Furthermore, the 5B4 antigen of the 
mature  brain  is  a  very sparse  molecule whereas the  other 
mature antigens seem to be as abundant as their fetal coun- 
terparts.  A  more  detailed  comparison  of 5B4  with  these 
antigens has to await immunochemical studies with the ap- 
propriate reagents. 
Conclusion 
The preparation of a GCP membrane fraction, the genera- 
tion of mAb's to GCP components, and the use of a differ- 
ELLIS  ET  AL.  Neurite  Growth  associated  Glycoprotein  1987 ential  screening  assay  have  enabled  us  to  identify  a  large 
membrane glycoprotein  that  seems to be associated  specifi- 
cally with neurite growth. While the close correlation between 
the expression of the fetal 5B4 antigen and neurite elongation 
suggests  that  this  glycoprotein  is  involved  in  a  mechanism 
related  to or coincident  with  neurite growth,  its function  is 
unknown.  Even  so,  the  fetal  5B4  antigen  is likely to  prove 
very useful as a molecular marker of neurite growth. 
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